Masaki Ri
0000-0002-9617-486X
11 papers found
Refreshing results…
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, Phase 1/2, safety and efficacy study
Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma
Clinical utility of target capture‐based panel sequencing in hematological malignancies: a multicenter feasibility study
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma
Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma
Immunohistochemistry for identification ofCCND1,NSD2, andMAFgene rearrangements in plasma cell myeloma
Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma
Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma
Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma
Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma
Missing publications? Search for publications with a matching author name.